A Long Intergenic Non-coding RNA, LINC01426, Promotes Cancer Progression via AZGP1 and Predicts Poor Prognosis in Patients with LUAD
Various long non-coding RNAs (lncRNAs) are closely associated with lung adenocarcinoma (LUAD), playing oncogenic or anti-oncogenic roles in tumorigenesis and progression. Herein, we report a novel lncRNA—long intergenic non-protein coding RNA 1426 (LINC01426)—that has not yet been characterized in L...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-09-01
|
Series: | Molecular Therapy: Methods & Clinical Development |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2329050120301674 |
_version_ | 1819206312664236032 |
---|---|
author | Baorui Tian Xiaoyang Han Guanzhen Li Hua Jiang Jianni Qi Jiamei Li Yingying Tian Chuanxi Wang |
author_facet | Baorui Tian Xiaoyang Han Guanzhen Li Hua Jiang Jianni Qi Jiamei Li Yingying Tian Chuanxi Wang |
author_sort | Baorui Tian |
collection | DOAJ |
description | Various long non-coding RNAs (lncRNAs) are closely associated with lung adenocarcinoma (LUAD), playing oncogenic or anti-oncogenic roles in tumorigenesis and progression. Herein, we report a novel lncRNA—long intergenic non-protein coding RNA 1426 (LINC01426)—that has not yet been characterized in LUAD. We note that LINC01426 expression was markedly upregulated in LUAD tissues, and that functional assays verified that LINC01426 knockdown markedly inhibited cell proliferation, migration, and invasion in vitro. Xenografts derived from A549 cells knocked down of LINC01426 had evidently lower tumor weights and smaller tumor volumes. Our study also found that LINC01426 bound to hsa-miR-30b-3p as a competitive endogenous RNA in LUAD. Moreover, LINC01426 affected LUAD wound healing by interacting and combining with AZGP1, and LINC01426 expression was significantly associated with tumor-node-metastasis (TNM) staging and prognosis in patients with LUAD. To summarize, our study elucidates the oncogenic roles of LINC01426 in LUAD tumorigenesis and progression. We think that LINC01426 can serve as a potential diagnostic biomarker and therapeutic target in patients with LUAD. |
first_indexed | 2024-12-23T05:05:36Z |
format | Article |
id | doaj.art-96068e7c909542d891d9fe64b8a749af |
institution | Directory Open Access Journal |
issn | 2329-0501 |
language | English |
last_indexed | 2024-12-23T05:05:36Z |
publishDate | 2020-09-01 |
publisher | Elsevier |
record_format | Article |
series | Molecular Therapy: Methods & Clinical Development |
spelling | doaj.art-96068e7c909542d891d9fe64b8a749af2022-12-21T17:59:05ZengElsevierMolecular Therapy: Methods & Clinical Development2329-05012020-09-0118765780A Long Intergenic Non-coding RNA, LINC01426, Promotes Cancer Progression via AZGP1 and Predicts Poor Prognosis in Patients with LUADBaorui Tian0Xiaoyang Han1Guanzhen Li2Hua Jiang3Jianni Qi4Jiamei Li5Yingying Tian6Chuanxi Wang7Department of Oncology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250021, ChinaDepartment of Oncology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250021, ChinaDepartment of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, ChinaDepartment of Thoracic Surgery, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, ChinaDepartment of Central Laboratory, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, ChinaDepartment of Pathology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, ChinaDepartment of Oncology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250021, ChinaDepartment of Oncology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250021, China; Department of Oncology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, 250021, China; Corresponding author: Chuanxi Wang, Department of Oncology, Shandong Provincial Hospital, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, 250021, ChinaVarious long non-coding RNAs (lncRNAs) are closely associated with lung adenocarcinoma (LUAD), playing oncogenic or anti-oncogenic roles in tumorigenesis and progression. Herein, we report a novel lncRNA—long intergenic non-protein coding RNA 1426 (LINC01426)—that has not yet been characterized in LUAD. We note that LINC01426 expression was markedly upregulated in LUAD tissues, and that functional assays verified that LINC01426 knockdown markedly inhibited cell proliferation, migration, and invasion in vitro. Xenografts derived from A549 cells knocked down of LINC01426 had evidently lower tumor weights and smaller tumor volumes. Our study also found that LINC01426 bound to hsa-miR-30b-3p as a competitive endogenous RNA in LUAD. Moreover, LINC01426 affected LUAD wound healing by interacting and combining with AZGP1, and LINC01426 expression was significantly associated with tumor-node-metastasis (TNM) staging and prognosis in patients with LUAD. To summarize, our study elucidates the oncogenic roles of LINC01426 in LUAD tumorigenesis and progression. We think that LINC01426 can serve as a potential diagnostic biomarker and therapeutic target in patients with LUAD.http://www.sciencedirect.com/science/article/pii/S2329050120301674LINC01426lung adenocarcinomahsa-miR-30b-3pAZGP1oncogene |
spellingShingle | Baorui Tian Xiaoyang Han Guanzhen Li Hua Jiang Jianni Qi Jiamei Li Yingying Tian Chuanxi Wang A Long Intergenic Non-coding RNA, LINC01426, Promotes Cancer Progression via AZGP1 and Predicts Poor Prognosis in Patients with LUAD Molecular Therapy: Methods & Clinical Development LINC01426 lung adenocarcinoma hsa-miR-30b-3p AZGP1 oncogene |
title | A Long Intergenic Non-coding RNA, LINC01426, Promotes Cancer Progression via AZGP1 and Predicts Poor Prognosis in Patients with LUAD |
title_full | A Long Intergenic Non-coding RNA, LINC01426, Promotes Cancer Progression via AZGP1 and Predicts Poor Prognosis in Patients with LUAD |
title_fullStr | A Long Intergenic Non-coding RNA, LINC01426, Promotes Cancer Progression via AZGP1 and Predicts Poor Prognosis in Patients with LUAD |
title_full_unstemmed | A Long Intergenic Non-coding RNA, LINC01426, Promotes Cancer Progression via AZGP1 and Predicts Poor Prognosis in Patients with LUAD |
title_short | A Long Intergenic Non-coding RNA, LINC01426, Promotes Cancer Progression via AZGP1 and Predicts Poor Prognosis in Patients with LUAD |
title_sort | long intergenic non coding rna linc01426 promotes cancer progression via azgp1 and predicts poor prognosis in patients with luad |
topic | LINC01426 lung adenocarcinoma hsa-miR-30b-3p AZGP1 oncogene |
url | http://www.sciencedirect.com/science/article/pii/S2329050120301674 |
work_keys_str_mv | AT baoruitian alongintergenicnoncodingrnalinc01426promotescancerprogressionviaazgp1andpredictspoorprognosisinpatientswithluad AT xiaoyanghan alongintergenicnoncodingrnalinc01426promotescancerprogressionviaazgp1andpredictspoorprognosisinpatientswithluad AT guanzhenli alongintergenicnoncodingrnalinc01426promotescancerprogressionviaazgp1andpredictspoorprognosisinpatientswithluad AT huajiang alongintergenicnoncodingrnalinc01426promotescancerprogressionviaazgp1andpredictspoorprognosisinpatientswithluad AT jianniqi alongintergenicnoncodingrnalinc01426promotescancerprogressionviaazgp1andpredictspoorprognosisinpatientswithluad AT jiameili alongintergenicnoncodingrnalinc01426promotescancerprogressionviaazgp1andpredictspoorprognosisinpatientswithluad AT yingyingtian alongintergenicnoncodingrnalinc01426promotescancerprogressionviaazgp1andpredictspoorprognosisinpatientswithluad AT chuanxiwang alongintergenicnoncodingrnalinc01426promotescancerprogressionviaazgp1andpredictspoorprognosisinpatientswithluad AT baoruitian longintergenicnoncodingrnalinc01426promotescancerprogressionviaazgp1andpredictspoorprognosisinpatientswithluad AT xiaoyanghan longintergenicnoncodingrnalinc01426promotescancerprogressionviaazgp1andpredictspoorprognosisinpatientswithluad AT guanzhenli longintergenicnoncodingrnalinc01426promotescancerprogressionviaazgp1andpredictspoorprognosisinpatientswithluad AT huajiang longintergenicnoncodingrnalinc01426promotescancerprogressionviaazgp1andpredictspoorprognosisinpatientswithluad AT jianniqi longintergenicnoncodingrnalinc01426promotescancerprogressionviaazgp1andpredictspoorprognosisinpatientswithluad AT jiameili longintergenicnoncodingrnalinc01426promotescancerprogressionviaazgp1andpredictspoorprognosisinpatientswithluad AT yingyingtian longintergenicnoncodingrnalinc01426promotescancerprogressionviaazgp1andpredictspoorprognosisinpatientswithluad AT chuanxiwang longintergenicnoncodingrnalinc01426promotescancerprogressionviaazgp1andpredictspoorprognosisinpatientswithluad |